It’s the newest buzzword in health care and one that’s getting attention across the country.
HealthSmart is a pill made by the company Ciroc, a subsidiary of AstraZeneca that promises to improve sleep and wellbeing.
It’s a pill that promises the benefits of sleep pills, including improved sleep and relaxation.
The company’s sales have surged.
But its main selling point is its lack of side effects, which has drawn scrutiny from experts.
So what exactly does HealthSmart do?
When you swallow the pill, a sensor in your nose and throat detects if it’s too cold or too hot.
If it’s warm or too cold, the pill releases a mild cooling effect that lets you sleep better and is more effective.
The pill’s makers claim the pill is 99 per cent effective and can reduce the risk of heart attacks and strokes by 30 per cent.
“You know when you’re trying to sleep and you don’t have a lot of energy, you feel like you’re floating and you’re not sure where you’re going to be, so you get up and get your head down, and the pill just keeps it in,” said Rachel Schaeffer, a physician and sleep specialist at the University of British Columbia in Vancouver.
“I’ve heard from people, I know they’ve heard it from their friends and family, that it has a calming effect.”
HealthSmart also promises to help prevent the spread of a rare but serious illness called sleep apnea.
According to the Canadian Sleep Foundation, about one in five Canadians have sleep apneas and they can lead to fatigue and difficulty falling asleep.
HealthSense is the second new pill to hit the market in Canada this year.
That one, called HealthSense, has also been tested in clinical trials and has been proven effective.
“We are seeing the promise of the products that we have, but we are also seeing some of the challenges that we need to address, like how we measure efficacy,” said Elizabeth Matson, a spokesperson for the Canadian Institutes of Health Research.
The pill is also available in several other countries including the United Kingdom, United States and Mexico.
HealthSense’s makers have also announced plans to expand in the U.K.
HealthCare has seen its share of breakthrough products come and go over the years.
It has been criticized for being too focused on a single product category, but HealthSmart has also seen several successes, including a sleep pill that has been credited with saving a man’s life and preventing heart attacks in older people.
HealthPlus, which was introduced by Astra Zeneca in 2001, was also a breakthrough product.
HealthPlus is a sleeping pill that uses a cooling gel that can help you stay warm during the night and is also effective at preventing heart disease and stroke.
It is currently only available in Canada.
However, HealthPlus was criticized for not working with physicians and patients to find the best treatments.
The drug company eventually discontinued the product.
In the last two years, HealthSense has also made waves in the medical community.
A few years ago, the company’s first trial of its SleepSmart pill found that it had significant results.
In March, the FDA approved HealthSense for use in adults over the age of 65.
It was also recently approved by the U,S.
Food and Drug Administration, which said it would begin to sell the drug in April.
However the drug is only available as a single pill.
The Canadian Health Alliance said HealthSense is only effective for adults.
“I have heard from patients that it is only efficacious for adults,” said Stephanie Beaudoin, a registered nurse at the Canadian Medical Association of Canada.
“We have to do more research on what the best treatment is for older people.”
Beaudoin said she was excited to hear that HealthSmart was being tested for potential use in the elderly population.
“My hope is that they have a product that is going to work for younger people, but the way they’ve designed it, I’m hoping it’s going to also work for older adults as well,” she said.